While potty training is probably a distant childhood memory, the panicked feeling of “I need to pee right now and I don’t know if I can make it to the bathroom in time” is something many adults still ...

Standard stepwise therapy for overactive bladder (OAB) begins with conservative therapies such as lifestyle interventions and behavioral approaches. Medications—anticholinergics or beta-3 agonists—are ...

Overactive bladder is a long-term condition that won’t go away on its own and may worsen if a person does not get treatment. The condition can be caused by issues in how the brain and bladder ...

The "Overactive Bladder Treatment Market by Pharmacotherapy and Disease Type - Global Forecast to 2022" report has been added to Research and Markets' offering. The global overactive bladder treatment ...

Women with overactive bladder are frequently frustrated with treatment, which leads to discontinuation of therapy. Asynchronous telehealth visits keep women engaged in follow-up care, accelerates ...

New analyses of data from the Phase 3 EMPOWUR Extension Study of GEMTESA® (vibegron) 75 mg provided additional insight into the long-term effects of the product. These data were featured in podium ...

Gemtesa is an oral, once-daily, small molecule beta-3 adrenergic agonist. Gemtesa ® (vibegron; Urovant Sciences) is now available for the treatment of overactive bladder (OAB) with symptoms of urge ...

NEW YORK, Oct. 21, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Overactive Bladder Treatment Market Size, Share, Revenue, Growth Strategy, Industry Trends and Forecast ...

DEAR DR. ROACH: Is there a cure for overactive bladder? — R.H. ANSWER: The underlying reason for overactive bladder is not well understood, and although there are medications to treat symptoms, there ...